N
BBNX

Nuveen’s Beta Bionics BBNX Stock Holding History

Nuveen’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$861K Buy
85,928
+549
+0.6% +$8.12K ﹤0.01% 2649
2025
Q4 		$2.6M Buy
85,379
+31,889
+60% +$852K ﹤0.01% 2178
2025
Q3 		$1.06M Buy
53,490
+36,446
+214% +$640K ﹤0.01% 2598
2025
Q2 		$248K Hold
17,044
– – ﹤0.01% 3109
2025
Q1 		$209K Buy
+17,044
New +$318K ﹤0.01% 3127

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nuveen's BBNX Position: Q1 2026 in Review

Nuveen increased its Beta Bionics (BBNX) stake by 0.64% in Q1 2026, buying an estimated $8.12K and bringing the position to 85,928 shares worth $861K. The position accounts for ﹤0.01% of the portfolio, ranked #2649.

Nuveen first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.6M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Nuveen held 85,928 shares of Beta Bionics worth $861K as of Q1 2026.
  • Nuveen bought 549 Beta Bionics shares in Q1 2026, an estimated $8.12K.
  • Beta Bionics made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2649 holding.
  • Nuveen first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Nuveen's Beta Bionics position peaked at $2.6M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.